Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Interferon β-1b directly modulates human neural stem/progenitor cell fate.
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting
Raxone®/Catena® (idebenone)
Genzyme’s once-daily, oral AUBAGIO® approved in Australia for treatment of relapsing multiple sclerosis
New Drugs Online report for idebenone
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Rituximab product approval information - Licensing action
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Development of cladribine at Scripps for hairy cell leukemia and current results.
Receptos doses first patient in Phase 2 trial for RPC1063 in ulcerative colitis
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.

Pages